Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | 48 875 | déclaré | 21 juin 2016 | tx 5+100 067 |
| PFIZER INC | 29 099,96 | déclaré | 23 avr. 2015 | tx 5+27 137,68 |
| Denali Therapeutics Inc. | 18 111 | déclaré | 03 juin 2025 | tx 73+637 176−1 576 887 |
| Juno Therapeutics, Inc. | 12 000 | déclaré | 17 juin 2016 | tx 4+199 000−175 000 |
| REGENERON PHARMACEUTICALS, INC. | 2 434 | déclaré | 03 janv. 2023 | tx 125+224 806−202 817 |
| GENENTECH INC | 0 | déclaré | 26 mars 2009 | tx 9+18 750−303 284 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 03 juin 2025 | GRANT_AWARD | Denali Therapeutics Inc. | 6 037 | 0.00 USD | |
| 03 juin 2025 | GRANT_AWARD | Denali Therapeutics Inc. | 18 111 | 0.00 USD | deriv |
| 31 mai 2024 | GRANT_AWARD | Denali Therapeutics Inc. | 5 967 | 0.00 USD | |
| 31 mai 2024 | GRANT_AWARD | Denali Therapeutics Inc. | 17 901 | 0.00 USD | deriv |
| 01 juin 2023 | GRANT_AWARD | Denali Therapeutics Inc. | 4 216 | 0.00 USD | |
| 01 juin 2023 | GRANT_AWARD | Denali Therapeutics Inc. | 12 649 | 0.00 USD | deriv |
| 03 janv. 2023 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 165 | 0.00 USD | |
| 03 janv. 2023 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1 929 | 0.00 USD | deriv |
| 03 janv. 2023 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 165 | 0.00 USD | |
| 03 janv. 2023 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1 929 | 0.00 USD | deriv |
| 23 nov. 2022 | SALE | Denali Therapeutics Inc. | 20 000 | 30.48 USD | |
| 02 nov. 2022 | SALE | Denali Therapeutics Inc. | 11 252 | 30.33 USD | |
| 01 nov. 2022 | SALE | Denali Therapeutics Inc. | 8 748 | 30.20 USD | |
| 29 sept. 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 80 | 699.82 USD | |
| 29 sept. 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 16 | 702.36 USD | |
| 29 sept. 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 20 | 704.83 USD | |
| 30 sept. 2022 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3 428 | 413.33 USD | |
| 30 sept. 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 3 428 | 698.00 USD | |
| 03 oct. 2022 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3 612 | 413.33 USD | |
| 03 oct. 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 3 612 | 718.00 USD | |
| 29 sept. 2022 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3 798 | 413.33 USD | |
| 29 sept. 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 16 | 686.89 USD | |
| 29 sept. 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 321 | 687.90 USD | |
| 29 sept. 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 208 | 698.44 USD | |
| 29 sept. 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 160 | 697.29 USD |